600 related articles for article (PubMed ID: 22955364)
21. Pattern of Candida species isolated from patients with diabetes mellitus and vulvovaginal candidiasis and their response to single dose oral fluconazole therapy.
Goswami D; Goswami R; Banerjee U; Dadhwal V; Miglani S; Lattif AA; Kochupillai N
J Infect; 2006 Feb; 52(2):111-7. PubMed ID: 15908007
[TBL] [Abstract][Full Text] [Related]
22. Lactobacilli-containing vaginal probiotics to cure or prevent bacterial or fungal vaginal dysbiosis: a systematic review and recommendations for future trial designs.
van de Wijgert J; Verwijs MC
BJOG; 2020 Jan; 127(2):287-299. PubMed ID: 31299136
[TBL] [Abstract][Full Text] [Related]
23. The innovative potential of Lactobacillus rhamnosus LR06, Lactobacillus pentosus LPS01, Lactobacillus plantarum LP01, and Lactobacillus delbrueckii Subsp. delbrueckii LDD01 to restore the "gastric barrier effect" in patients chronically treated with PPI: a pilot study.
Del Piano M; Anderloni A; Balzarini M; Ballarè M; Carmagnola S; Montino F; Orsello M; Pagliarulo M; Tari R; Soattini L; Sforza F; Mogna L; Mogna G
J Clin Gastroenterol; 2012 Oct; 46 Suppl():S18-26. PubMed ID: 22955351
[TBL] [Abstract][Full Text] [Related]
24. Vaginal colonisation by probiotic lactobacilli and clinical outcome in women conventionally treated for bacterial vaginosis and yeast infection.
Pendharkar S; Brandsborg E; Hammarström L; Marcotte H; Larsson PG
BMC Infect Dis; 2015 Jul; 15():255. PubMed ID: 26137971
[TBL] [Abstract][Full Text] [Related]
25. Local Probiotic Therapy for Vaginal Candida albicans Infections.
Kovachev SM; Vatcheva-Dobrevska RS
Probiotics Antimicrob Proteins; 2015 Mar; 7(1):38-44. PubMed ID: 25362524
[TBL] [Abstract][Full Text] [Related]
26. Probiotics and vaginal microecology: fact or fancy?
Buggio L; Somigliana E; Borghi A; Vercellini P
BMC Womens Health; 2019 Jan; 19(1):25. PubMed ID: 30704451
[TBL] [Abstract][Full Text] [Related]
27. Genital Candida species detected in samples from women in Melbourne, Australia, before and after treatment with antibiotics.
Pirotta MV; Garland SM
J Clin Microbiol; 2006 Sep; 44(9):3213-7. PubMed ID: 16954250
[TBL] [Abstract][Full Text] [Related]
28. In Vitro Activity of Lactobacillus fermentum LF5 Against Different Candida Species and Gardnerella vaginalis: A New Perspective to Approach Mixed Vaginal Infections?
Deidda F; Amoruso A; Allesina S; Pane M; Graziano T; Del Piano M; Mogna L
J Clin Gastroenterol; 2016; 50 Suppl 2, Proceedings from the 8th Probiotics, Prebiotics & New Foods for Microbiota and Human Health meeting held in Rome, Italy on September 13-15, 2015():S168-S170. PubMed ID: 27741167
[TBL] [Abstract][Full Text] [Related]
29. Interpretation of vaginal metagenomic characteristics in different types of vaginitis.
Song J; Dong X; Lan Y; Lu Y; Liu X; Kang X; Huang Z; Yue B; Liu Y; Ma W; Zhang L; Yan H; He M; Fan Z; Guo T
mSystems; 2024 Mar; 9(3):e0137723. PubMed ID: 38364107
[TBL] [Abstract][Full Text] [Related]
30. Improved treatment of vulvovaginal candidiasis with Clotrimazole plus probiotic Lacidophilin Vaginal Capsules: A prospective, real-world study.
Zeng X; An R; Li H; Zhang Y
Medicine (Baltimore); 2023 Jan; 102(1):e32664. PubMed ID: 36607885
[TBL] [Abstract][Full Text] [Related]
31. Comparing the therapeutic potentials of
ElFeky DS; Awad AR; Shamseldeen AM; Mowafy HL; Hosny SA
Front Microbiol; 2023; 14():1222503. PubMed ID: 37529322
[TBL] [Abstract][Full Text] [Related]
32. Impact of
Mändar R; Sõerunurk G; Štšepetova J; Smidt I; Rööp T; Kõljalg S; Saare M; Ausmees K; Le DD; Jaagura M; Piiskop S; Tamm H; Salumets A
Benef Microbes; 2023 Apr; 14(2):143-152. PubMed ID: 36856121
[TBL] [Abstract][Full Text] [Related]
33. The in vitro activity of vaginal Lactobacillus with probiotic properties against Candida.
Strus M; Kucharska A; Kukla G; Brzychczy-Włoch M; Maresz K; Heczko PB
Infect Dis Obstet Gynecol; 2005 Jun; 13(2):69-75. PubMed ID: 16011996
[TBL] [Abstract][Full Text] [Related]
34. Thymol, eugenol and lactobacilli in a medical device for the treatment of bacterial vaginosis and vulvovaginal candidiasis.
Murina F; Vicariotto F; Di Francesco S
New Microbiol; 2018 Jul; 41(3):220-224. PubMed ID: 29874389
[TBL] [Abstract][Full Text] [Related]
35. Efficacy and safety of a vaginal medicinal product containing three strains of probiotic bacteria: a multicenter, randomized, double-blind, and placebo-controlled trial.
Tomusiak A; Strus M; Heczko PB; Adamski P; Stefański G; Mikołajczyk-Cichońska A; Suda-Szczurek M
Drug Des Devel Ther; 2015; 9():5345-54. PubMed ID: 26451088
[TBL] [Abstract][Full Text] [Related]
36. Improved treatment of vulvovaginal candidiasis with fluconazole plus probiotic Lactobacillus rhamnosus GR-1 and Lactobacillus reuteri RC-14.
Martinez RC; Franceschini SA; Patta MC; Quintana SM; Candido RC; Ferreira JC; De Martinis EC; Reid G
Lett Appl Microbiol; 2009 Mar; 48(3):269-74. PubMed ID: 19187507
[TBL] [Abstract][Full Text] [Related]
37. Probiotics for vulvovaginal candidiasis in non-pregnant women.
Xie HY; Feng D; Wei DM; Mei L; Chen H; Wang X; Fang F
Cochrane Database Syst Rev; 2017 Nov; 11(11):CD010496. PubMed ID: 29168557
[TBL] [Abstract][Full Text] [Related]
38. The bacterial communities in vagina of different Candida species-associated vulvovaginal candidiasis.
Chen Z; Jin J; Chen H; Chen Y; Feng S
Microb Pathog; 2023 Apr; 177():106037. PubMed ID: 36842517
[TBL] [Abstract][Full Text] [Related]
39. Vaginal colonization and activity of the probiotic bacterium Lactobacillus fermentum L23 in a murine model of vaginal tract infection.
Pascual L; Ruiz F; Giordano W; Barberis IL
J Med Microbiol; 2010 Mar; 59(Pt 3):360-364. PubMed ID: 19926731
[TBL] [Abstract][Full Text] [Related]
40. Prevalence of vulvovaginal candidiasis in pregnancy at three health centers in Burkina Faso.
Sangaré I; Sirima C; Bamba S; Zida A; Cissé M; Bazié WW; Sanou S; Dao B; Menan H; Guiguemdé RT
J Mycol Med; 2018 Mar; 28(1):186-192. PubMed ID: 28939305
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
